Zynerba Pharmaceuticals, Inc. Soared
Mon, Aug 14, 2023 at 07:29 PM
Zynerba Pharmaceuticals, Inc. (ZYNE:NASDAQ) shot up at $1.35, representing a gain of 298.2%. On Mon, Aug 14, 2023, ZYNE:NASDAQ touched a New 2-Week High of $1.35. The stock appeared on our News Catalysts scanner on Mon, Aug 14, 2023 at 01:03 PM in the 'ACQUISITION' category. From Mon, Jul 31, 2023, the stock recorded 20.00% Up Days and 9.09% Green Days
About Zynerba Pharmaceuticals, Inc. (ZYNE:NASDAQ)
Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery.
Top 10 Gainers:
- Zynerba Pharmaceuticals, Inc. (ZYNE:NASDAQ), 298.23%
- Taysha Gene Therapies Inc. (TSHA:NASDAQ), 188.23%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 70.18%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 44.97%
- MOGU Inc. (MOGU:NYSE), 37.93%
- U Power Limited (UCAR:NASDAQ), 37.65%
- Paranovus Entertainment Technology Ltd Ord (New) (PAVS:NASDAQ), 37.61%
- Castellum Inc. (CTM:NYSEMKT), 37.18%
- United States Steel Corporation (X:NYSE), 36.8%
- Genius Group Limited (GNS:NYSEMKT), 33.61%